| Literature DB >> 22403696 |
Rodrigo Octávio Deliberato1, Alexandre R Marra, Thiago Domingos Corrêa, Marinês Dalla Vale Martino, Luci Correa, Oscar Fernando Pavão Dos Santos, Michael B Edmond.
Abstract
BACKGROUND: Approximately 150 million central venous catheters (CVC) are used each year in the United States. Catheter-related bloodstream infections (CR-BSI) are one of the most important complications of the central venous catheters (CVCs). Our objective was to compare the in-hospital mortality when the catheter is removed or not removed in patients with CR-BSI.Entities:
Mesh:
Year: 2012 PMID: 22403696 PMCID: PMC3293859 DOI: 10.1371/journal.pone.0032687
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the patients with CR-BSI.
| Standard methodN = 37 | Conservative methodN = 16 | p-value | OR 95% CI | |
|
| ||||
| Age, mean ± SD | 66.83±20.10 | 59.31±16.6 | 0.2 | |
| Male gender | 17 (45%) | 11 (68%) | 0.127 | 0.39 (0.11–1.33) |
| Parenteral nutrition | 13 (35%) | 08 (50%) | 0.31 | 1.85 (0.56–6.07) |
| Indwelling bladder catheter | 32 (86%) | 14 (88%) | 0.92 | 1.09 (0.19–6.33) |
| Vasoactive drug | 22 (59%) | 07 (44%) | 0.292 | 0.53 (0.16–1.74) |
| Mechanical ventilation | 31 (84%) | 09 (56%) | 0.032 | 0.25 (0.07–0.93) |
| Acute renal failure | 23 (62%) | 10 (62%) | 0.981 | 1.01 (0.30–3.40) |
| Coagulation disorder | 04 (11%) | 04 (25%) | 0.151 | 3 (0.64–14.06) |
| Dialysis | 13 (35%) | 08 (50%) | 0.31 | 1.85 (0.56–6.07) |
| Prior antibiotic therapy | 32 (86%) | 13 (81%) | 0.625 | 0.68 (0.14–3.25) |
| Adequate treatment in 1st 24 hours | 15 (40%) | 07 (44%) | 0.828 | 1.14 (0.35–3.73) |
| Lenght of hospital stay before bacteremia (days) median (range) | 25 (3–245) | 24.5 (9–143) | 0.69 | |
| Blood transfusion | 12 (32%) | 05 (31%) | 0.933 | 0.95 (0.27–3.34) |
| Septic shock | 26 (70%) | 12 (75%) | 0.726 | 1.27 (0.33–4.81) |
|
| ||||
| APACHE II at admission, mean ± SD | 12.16±5.29 | 11.88±7.81 | 0.89 | |
| SAPS II at admission, mean ± SD | 36.03±12.52 | 29.50±13.23 | 0.1 | |
| SOFA at admission, mean ± SD | 3.81±4.36 | 03.69±3.38 | 0.92 | |
| APACHE II bacteremia, mean ± SD | 15.43±4.62 | 15.44±4.43 | 0.99 | |
| SAPS II bacteremia, mean ± SD | 43.05±12.64 | 38.06±12.91 | 0.2 | |
| SOFA bacteremia, mean ± SD | 06.97±04.41 | 07.06±03.43 | 0.94 | |
| Charlson >3 | 3.2±2.6 | 3.6±2.5 | 0.59 | −0.41 (−1.96–1.14) |
|
| ||||
| CVC insertion site: | ||||
| Anterior jugular vein | 33 (89.2%) | 16 (100%) | ||
| Subclavian vein | 2 (5.4%) | - | ||
| Femoral vein | 1 (2.7%) | - | ||
| External jugular vein | 1 (2.7%) | - | ||
| Type of CVC: | ||||
| Double lumen | 29 (78.4%) | 9 (56.3%) | ||
| Dialysis catheter | 1 (2.7%) | - | ||
| Triple lumen | 7 (18.2%) | 7 (43.8%) | ||
| CVC indwelling time (days), mean ± SD | 17±9.2 | 14.8±6.8 | 0.35 | 2.16 (−2.43–6.75) |
|
| ||||
| ICU mortality | 17 (46%) | 12 (75%) | 0.051 | 3.52 (0.96–12.99) |
| In-hospital mortality | 21 (57%) | 12 (75%) | 0.208 | 2.29 (0.62–8.43) |
CVC = central venous catheter; SAPS II = simplified acute physiology score; SOFA = Sepsis-related Organ Failure Assessment; APACHE II = Acute Physiology and Chronic Health disease Classification System II, Charlson = comorbidity index.
Microbiological features by diagnostic method.
| Conservative method16 cases | Standard method37 cases | |
|
|
|
|
|
| 2 (33.3%) | 8 (47%) |
|
| 1 (16.7%) | 1 (5.9%) |
|
| 1 (16.7%) | 1 (5.9%) |
|
| - | 1 (5.9%) |
|
| - | 2 (11.8%) |
|
| - | 2 (11.8%) |
|
| - | 2 (11.8%) |
|
| 1 (16.7%) | - |
|
| 1 (16.7%) | - |
|
|
|
|
|
| 1 (33.3%) | 2 (28.6%) |
|
| - | 1 (14.3%) |
|
| 1 (33.3%) | 4 (57.1%) |
|
| 1 (33.3%) | - |
|
|
|
|
|
| 3 (42.9%) | 6 (46.2%) |
|
| 1 (14.3%) | 5 (38.5%) |
|
| - | 1 (7.7%) |
|
| 2 (28.6%) | - |
|
| 1 (14.3%) | - |
|
| - | 1 (7.7%) |
Risk factors for in-hospital mortality.
| Non-survivorsN = 33 | SurvivorsN = 20 | p-value | Univariate analysisOR (95% CI) | Multivariate analysisOR (95% CI) | |
| Mean age ± SD | 69.55±18.22 | 56.35±18.58 | 0.016 | 1.03 (0.99–1.07) | |
| Male gender | 19 (57%) | 9 (45%) | 0.374 | 0.60 (0.2–1.84) | |
| Respiratory dysfunction | 26 (78%) | 13 (65%) | 0.471 | 1.6 (0.45–5.66) | |
| Cardiovascular dysfunction | 22 (66%) | 8 (40%) | 0.58 | 3 (0.95–9.48) | |
| Renal dysfunction | 27 (82%) | 9 (45%) | 0.005 | 5.5 (1.58–19.17) | 5.5 (1.3–22.4) |
| Hematologic dysfunction | 23 (70%) | 4 (20%) | <0.001 | 9.2 (2.45–34.56) | |
| Liver dysfunction | 10 (30%) | 2 (10%) | 0.87 | 3.9 (0.76–20.15) | |
| Conservative method | 12 (36%) | 4 (20%) | 0.208 | 2.28 (0.62–8.43) | |
| Adequate antimicrob ther 1st 24 h | 12 (36%) | 10 (50%) | 0.329 | 0.57 (0.18–1.76) | |
| Septic shock | 28 (85%) | 10 (50%) | 0.006 | 5.6 (1.54–20.42) | |
| Charlson >3 | 19 (57%) | 7 (35%) | 0.854 | 1.1 (0.36–3.40) | |
| APACHEII bacteremia, mean ± SD | 16.70±4.09 | 13.35±4.51 | 0.01 | 1.1 (0.93–1.33) | |
| SAPS II bacteremia, mean ± SD | 44.30±11.51 | 37±13.83 | 0.04 | 1.0 (0.95–1.07) | |
| SOFA bacteremia, mean ± SD | 7.70±3.91 | 5.85±4.27 | 0.120 | ||
| Prior ICU admission | 23 (69%) | 10 (50%) | 0.152 | 2.3 (0.73–7.25) |
CVC = central venous catheter; SAPS II = simplified acute physiology score; SOFA = Sepsis-related Organ Failure Assessment; APACHE II = Acute Physiology and Chronic Health disease Classification System II, Charlson = comorbidity index.